Phase I study of TS-1 with paclitaxel for gastric carcinomatosa

Phase I study of TS-1 with paclitaxel for gastric carcinomatosa - Phase I study of TS-1 with paclitaxel for gastric carcinomatosa

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002496

Enrollment

Registered

2010-10-01

Start date

2009-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer dissemination

Interventions

paclitaxel

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: stage IV gastric cancer

Exclusion criteria

Exclusion criteria: guideline

Design outcomes

Primary

Measure	Time frame
safety	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026